Background
==========

Oral cancer is one of the most prevalent malignancies around the world, with an estimated 300,000 new cases and 130,000 deaths every year worldwide \[[@b1-medscimonit-23-5924]\]. Tongue squamous cell carcinoma (TSCC) is a major type of oral cancer, which is characterized by remarkably aggressive biological behavior with a high incidence of lymph node and distant metastasis \[[@b2-medscimonit-23-5924]\]. Although, the 5-year survival rate is reported to be up to 50% with early detection, most patients are diagnosed at a late stage, leading to poorer prognosis \[[@b3-medscimonit-23-5924]\] and resulting in complications such as the malfunction of mastication, speech, and deglutition, or death. Despite advances in surgical procedures and chemo-radiotherapy, as well as the advent of targeted therapy, clinical outcomes have remained unchanged for decades \[[@b4-medscimonit-23-5924]\]. Therefore, it is of primary importance to identify the etiological factors, molecular mechanisms, and pathways of carcinogenesis to discover novel diagnostic and treatment strategies for TSCC.

The molecular pathogenesis of carcinogenesis may be a combination of somatic mutations \[[@b5-medscimonit-23-5924]\], and epigenetic and transcriptional alterations. Aberrant genetic alterations in gene expression may lead to the malignant transformation of TSCC. With advances of sequencing and high-throughput DNA microarray analyses, numerous gene alterations manifesting differentially expressed genes (DEGs) have been demonstrated to be correlated with the genesis and progression of tumors \[[@b6-medscimonit-23-5924]\]. For example, Nadia et al. \[[@b7-medscimonit-23-5924]\] found a significant association between methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and p16 and O6-methylguanine-DNA methyltransferase (MGMT) gene promoter methylation in oral squamous cell cancer (OSCC) patients, which suggests that hypermethylation of cancer-related genes may be affected by MTHFR polymorphisms. Metastasis-associated lung adenocarcinoma transcript 1 (MALAT1), a long non-coding RNA (lncRNA), may play an oncogenic role by increasing proliferation and metastasis of tongue cancer via miR-124-dependent jagged1 (JAG1) regulation \[[@b8-medscimonit-23-5924]\]. Obvious genetic genes changes, including loss of TRAF3 and amplification of E2F1 (a cell cycle gene), have been found in head and neck squamous carcinoma \[[@b5-medscimonit-23-5924]\]. Chaisaingmongkol et al. \[[@b9-medscimonit-23-5924]\] found that NEIL1 (Nei endo-nuclease VIII-like 1 gene) promoter hypermethylation might have a function in mediating the response to treatment of head and neck squamous cell carcinoma (HNSCC). Also, various signaling pathways have been shown to be important, such as loss-of-function alterations of the WNT pathway \[[@b5-medscimonit-23-5924]\]; in addition, the COX-2 (cyclooxygenase-2) signaling pathway has been shown to be closely related to tumor angiogenesis \[[@b10-medscimonit-23-5924]\] in TSCC. Moreover, the importance of inflammation in carcinogenesis of TSCC has been proven \[[@b11-medscimonit-23-5924]\]; and Giovanni et al. \[[@b12-medscimonit-23-5924]\] found that transglutaminase 2 (TG2) played a key role in periodontal inflammatory disease through the nuclear factor-kappa B (NF-κB) pathway. Therefore, identifying DEGs and elucidating the interactions network among them, and the signal pathways, is essential for TSCC. Novel therapeutic biomarkers are needed for TSCC for predictive and curative purposes.

In the present study, the DEGs of TSCC and normal tissue samples were analyzed to achieve a better understanding of TSCC. GO and KEGG enrichment analyses of DEGs were applied, and the protein-protein interaction (PPI) network and module of these DEGs was also constructed. The aim of this study was to identify key genes and pathways in TSCC using bioinformatics analysis, and then to explore the intrinsic mechanisms of TSCC and distinguish novel potential diagnostic therapeutic biomarkers of TSCC. We anticipated that these studies will provide further insight of TSCC pathogenesis and development at the molecular level.

Material and Methods
====================

Datasets
--------

The Gene Expression Omnibus (GEO, *<http://www.ncbi.nlm.nih.gov/geo>*) is a public functional genomics data repository including array- and sequence-based data, and is freely available for users. The gene expression profiles of GSE13601 were obtained from the GEO database. GSE13601, which was based on the GPL8300 platform \[HG_U95Av2\] Affymetrix Human Genome U95 Version 2 Array, was submitted by Estilo et al. \[[@b13-medscimonit-23-5924]\]. The GSE13601 dataset has 57 samples, including 31 TSCC samples and 26 matched normal mucosa samples.

Data processing
---------------

GEO2R (*<http://www.ncbi.nlm.nih.gov/geo/geo2r/>*) is an online tool where different groups of samples from the GEO series can be compared so as to identify genes that are differentially expressed across experimental conditions \[[@b14-medscimonit-23-5924]\]. The analysis of screening DEGs between TSCC and normal mucosa samples was carried out by GEO2R. The adjusted *p* values (adj. *p*) were applied to correct the false positive results by default Benjamini-Hochberg false discovery rate method. The adj. *p*\<0.01 and \|log2FC\|\>1 were considered as the cutoff values.

Gene ontology (GO) and pathway enrichment analysis of DEGs
----------------------------------------------------------

The GO (*<http://www.geneontology.org>*) \[[@b15-medscimonit-23-5924]\] database can provide functional classification for genomic data, including categories of biological processes (BP), cellular component (CC), and molecular function (MF). GO analysis is a common genes and gene products annotating method. The Kyoto Encyclopedia of Genes and Genomes (KEGG, *<http://www.genome.ad.jp/kegg/>*) \[[@b16-medscimonit-23-5924]\] database is a knowledge base for systematic analysis, annotation, and visualization of gene functions. The Database for Annotation, Visualization and Integrated Discovery (DAVID, *<http://david.abcc.ncifcrf.gov/>*) \[[@b17-medscimonit-23-5924]\] is an online tool for gene functional classification, which is an essential foundation for high-throughput gene analysis to understand the biological significance of genes. In the present study, in order to analyze the functions of DEGs, GO enrichment and KEGG pathway analysis were conducted using the DAVID online tool; *p*\<0.05 was set as the cutoff point.

Integration of protein-protein interaction (PPI) network and module analysis
----------------------------------------------------------------------------

The Search Tool for the Retrieval of Interacting Genes (STRING, *<http://string.embl.de/>*) \[[@b18-medscimonit-23-5924]\] is a biological database designed to predict protein-protein interaction (PPI) information. The DEGs were mapped to STRING to evaluate the interactive relationships, with a confidence score \>0.9 defined as significant. Then, we use Cytoscape \[[@b19-medscimonit-23-5924]\], a biological graph visualization tool for integrated models of biologic molecular interaction networks software, to construct PPI networks. The Molecular Complex Detection (MCODE) \[[@b20-medscimonit-23-5924]\], a plugin for Cytoscape, was used to screen the modules of the PPI network. The criteria were set as follows: degree cutoff=2, node score cutoff=0.2, k-core=2 and maximum depth=100. Moreover, the function and pathway enrichment analysis were performed for DEGs in the modules.

Analysis of key nodes in the PPI network
----------------------------------------

The key genes in the PPI network were investigated topologically. Three centrality methods including degree, closeness, and subgraph centrality \[[@b21-medscimonit-23-5924]\] were used to explore key genes in the PPI network. The three centrality methods were calculated using the Cytoscape plugin: CytoNCA \[[@b22-medscimonit-23-5924]\].

Results
=======

Identification of DEGs
----------------------

A total of 31 TSCC samples and 26 matched normal mucosa samples were analyzed, the mean age was 57 years (36--97 years). Based on the GEO2R analysis, using the adj. *p*\<0.01 and \|log~2~FC\|\>1 criteria, a total of 1,752 DEGs were identified, consisting of 1,050 upregulated DEGs (uDEGs) and 702 downregulated DEGs (dDEGs) in TSCC tissues compared with normal tissues.

GO term enrichment analysis
---------------------------

To acquire further understanding of the functions of identified DEGs, all DEGs were uploaded to DAVID to identify significant GO categories and KEGG pathways. GO analysis results showed that uDEGs were markedly enriched in BP, including signal transduction, positive or negative regulation of cell proliferation, and negative regulation of cell proliferation ([Table 1](#t1-medscimonit-23-5924){ref-type="table"}); the dDEGs were enriched in signal transduction, cell adhesion, and apoptotic process ([Table 1](#t1-medscimonit-23-5924){ref-type="table"}). For MF, the uDEGs were enriched in protein, ATP, and calcium ion binding; and the dDEGs were enriched in protein, ATP, and poly (A) RNA binding ([Table 1](#t1-medscimonit-23-5924){ref-type="table"}). In addition, GO CC analysis showed that uDEGs were significantly enriched in the plasma membrane, cytosol, and extracellular exosome; and dDEGs were enriched in cytoplasm, nucleus, and cytosol ([Table 1](#t1-medscimonit-23-5924){ref-type="table"}).

KEGG pathway analysis
---------------------

The most significantly enriched pathways of uDEGs and dDEGs analyzed by KEGG analysis are shown in [Table 2](#t2-medscimonit-23-5924){ref-type="table"}. The uDEGs were enriched in metabolic pathways, pathways in cancer, PI3K-Akt signaling pathway, calcium signaling pathway, and MAPK signaling pathway, while the dDEGs were enriched in pathways in cancer, PI3K-Akt signaling pathway, focal adhesion, and ECM-receptor interaction.

PPI network construction and modules selection
----------------------------------------------

The PPI network of DEGs consisted of 1,616 nodes and 5,866 edges constructed in the STRING database (version 10.5) and visualized using Cytoscape software ([Figure 1](#f1-medscimonit-23-5924){ref-type="fig"}). Degree \>10 was set as the cutoff criterion. Based on the STRING database, the DEGs with the highest PPI scores identified by the three centrality methods are shown in [Table 3](#t3-medscimonit-23-5924){ref-type="table"}. After repeated genes were removed, the hub genes (shown in [Figure 1](#f1-medscimonit-23-5924){ref-type="fig"}, highlighted in red and shaped in diamond) were obtained using the three centrality methods, including RAC1 (ras-related C3 botulinum toxin substrate 1), APP (amyloid beta precursor protein), EGFR (epidermal growth factor receptor), KNG1 (kininogen 1), AGT (angiotensinogen), and HRAS (HRas proto-oncogene, GTPase). Among these genes, RAC1 showed the highest node degree, which was 78. A significant module was constructed from the PPI network of the DEGs using MCODE, including 43 nodes and 462 edges ([Figure 2](#f2-medscimonit-23-5924){ref-type="fig"}). Biological functional enrichment analysis showed that genes in this module were markedly enriched in signal transduction, single organism signaling, and cell communication ([Table 4](#t4-medscimonit-23-5924){ref-type="table"}). Neuroactive ligand-receptor interaction, calcium signaling pathway, and chemokine signaling pathway were enriched in the KEGG pathway analysis.

Discussion
==========

Despite advances in current therapeutics, TSCC has remained an intractable cancer over the past decades. Uncovering the etiological and molecular mechanisms of TSCC is of vital importance for therapy and prevention. Nowadays, with the rapid developing of DNA microarrays and high-throughput sequencing techniques, it is possible to research diseases, including cancers, at the gene level. DNA microarray gene expression profiling has been widely used to explore differentially expressed genes involved in tumor genesis, diagnosis, and therapeutic approaches \[[@b23-medscimonit-23-5924],[@b24-medscimonit-23-5924]\].

In this study, we extracted the data from GSE13601 and identified 1,050 uDEGs and 702 dDEGs between TSCC and normal tissue samples using bioinformatics analysis. These uDEGs were obviously enriched in metabolic pathways, pathways in cancer, and the PI3K-Akt signaling pathway which are intimately related to cancer. The dDEGs were predominantly enriched in pathways in cancer, the PI3K-Akt signaling pathway, and focal adhesion.

The uDEGs were shown to be mostly involved in signal transduction, positive or negative regulation of cell proliferation, and negative regulation of cell proliferation, while dDEGs were shown to be concerned with signal transduction, cell adhesion, and the apoptotic process in the GO term analysis. This conforms to the knowledge that signal transduction, regulating of cell proliferation, cell adhesion, and apoptotic process are all important mechanisms of tumor genesis, development, and progression \[[@b25-medscimonit-23-5924]--[@b30-medscimonit-23-5924]\]. Moreover, the enriched KEGG pathways of uDEGs included metabolic pathways, pathways in cancer, and the PI3K-Akt signaling pathway. Numbers of studies have shown that metabolic pathways and the PI3K-Akt signaling pathway play an important role in genesis and growing of squamous cell carcinoma of the oral tongue \[[@b31-medscimonit-23-5924]--[@b35-medscimonit-23-5924]\]. Zhang et al. \[[@b36-medscimonit-23-5924]\] reported that by rewiring alternative metabolic pathways, oral cancer cells may still survive when metabolic enzymes were silenced by siRNAs. Downregulated DEGs were also found to be involved in focal adhesion and ECM-receptor interaction. Exceedingly abnormal expression of focal adhesion kinase affected cellular proliferation and apoptosis \[[@b37-medscimonit-23-5924]\], served as a marker of cervical lymph node metastasis, and a potential therapeutic target of TSCC \[[@b38-medscimonit-23-5924]\]. Therefore, studying these signaling pathways could assist in the prediction of cancer progression.

The PPI network was constructed with DEGs and the top centrality hub genes were obtained: RAC1, APP, EGFR, KNG1, AGT, and HRAS. The genesis of tumor is an extremely complicated process during which lots of genetic and epigenetic modifications of driving genes occur. RAC1 was identified as one of the hub genes with the highest degree of connectivity. The protein encoded by RAC1 is a GTPase belonging to the RAS superfamily, members of which appear to be regulated widely in cellular events, such as controlling the cell growth and the activation of protein kinases. As an oncogene, RAC1 was associated with various cancers, such as melanoma, colorectal cancer, breast cancer, and glioma \[[@b39-medscimonit-23-5924]\]. Increased expression and subcellular localization of RAC1 could lead to lower early response rate and higher recurrences in head and neck squamous cell carcinomas (HNSCC), suggesting that it seems to be a potential therapeutic target for HNSCC patients of chemo-radiotherapy resistant \[[@b40-medscimonit-23-5924]\]. Patel et al. \[[@b41-medscimonit-23-5924]\] found that most HNSCC cells showed an outstandingly high level of RAC1, and the EGFR/Vav2/Rac1 axis was a critical pathway for the ability of invasion and metastasis of most HNSCC cells. APP has been well studied in the pathogenesis of Alzheimer disease. However, little is known concerning the role of APP in carcinogenesis. Gain-of-function studies have shown that APP overexpression leads to increased cellular proliferation. Loss-of-function studies, either by APP knockdown or blockage of APP function by antibody application, have demonstrated regression of carcinoma growth *in vitro* and*in vivo* \[[@b42-medscimonit-23-5924]\]*.* Recently, it was shown that APP was upregulated in several cancer species, including pancreatic \[[@b43-medscimonit-23-5924]\]*,* colon \[[@b44-medscimonit-23-5924]\], melanoma \[[@b45-medscimonit-23-5924]\], and prostate \[[@b46-medscimonit-23-5924]\] cancer and had growth-promoting features*.* APP expression was found to be involved in the carcinogenesis and proliferation of oral SCC cells, and could serve as a marker indicating oral cancer genesis \[[@b47-medscimonit-23-5924]\]. EGFR is a protein located on the cell surface binding to epidermal growth factor \[[@b48-medscimonit-23-5924]\]. When a ligand binds to EGFR, the receptor will dimerize and tyrosine will autophosphorylate, leading to cell proliferation. EGFR was overexpressed in about 30% of human epithelial tumors \[[@b49-medscimonit-23-5924]\], including HNSCCs \[[@b48-medscimonit-23-5924]\]. Ansell et al. found that the amount of EGF had a determinant function in cell proliferation and the response to treatment of cetuximab in tongue cancer, so EGF was a potential predictive biomarker of poor cetuximab response and a possible target of treatment \[[@b50-medscimonit-23-5924]\]. EGFR copy number alteration, rather than overexpression, was a better prognostic indicator in TSCC \[[@b51-medscimonit-23-5924]\]. Thus, EGFR was particularly important in the pathogenesis of TSCC. There is more and more evidence demonstrating a role for KNG1 in carcinogenesis \[[@b52-medscimonit-23-5924]\]. Liu et al. \[[@b53-medscimonit-23-5924]\] showed that KNG1 seemed to have a function of anti-angiogenesis and blocked the proliferation of endothelial cells. In addition, lower expression of KNG1 was detected in the serum of cancer patients, which was associated with cancer cells survival \[[@b54-medscimonit-23-5924]\]. Furthermore, KNG1 was shown to be a potential serum predictor of advanced colorectal adenoma and cancer \[[@b55-medscimonit-23-5924]\]. AGT, encoding angiotensinogen, has been shown to be a suppressor of tumor progression and metastasis. Overexpression of human AGT decreased angiogenesis and prohibited remodeling and neovascularization of tumor cells, thus delayed tumor advancement *in vivo* \[[@b24-medscimonit-23-5924],[@b56-medscimonit-23-5924]\]. Bouquet et al. \[[@b57-medscimonit-23-5924]\] demonstrated that AGT had a very powerful antiangiogenic function *in vivo*, independent of angiotensin II generation, representing a promising novel strategy to inhibit growth and metastasis of primary tumors. HRAS belongs to the Ras oncogene family; obvious mutations of the HRAS gene were found in oral cancer, suggesting that RAS may affect the tumorigenesis process \[[@b58-medscimonit-23-5924]\]. There was another interesting finding: activated HRAS mutations could overcome the resistance to erlotinib in an HNSCC cell line with HRAS mutation \[[@b59-medscimonit-23-5924]\]. In summary, the top centrality hub genes (RAC1, APP, EGFR, KNG1, AGT, and HRAS) obtained from the PPI network are all deeply involved in cancer genesis or progression process, which suggesting that these hub genes may serve as prognostic biomarkers or therapeutic targets for this disease.

Module analysis of the PPI network showed that TSCC was associated with neuroactive ligand-receptor interaction, calcium signaling pathway, and chemokine signaling pathway. Neuroactive ligand-receptor interaction has been shown to be involved in various kinds of cancers such as renal cell carcinoma \[[@b60-medscimonit-23-5924]\], breast cancer \[[@b61-medscimonit-23-5924]\], bladder cancer \[[@b62-medscimonit-23-5924]\], and lung adenocarcinoma \[[@b63-medscimonit-23-5924]\] when using pathways and gene interaction networks analysis. Moreover, the intracellular calcium overload could initiate mitochondrial-dependent apoptosis \[[@b64-medscimonit-23-5924]\], which is the most frequent strategy for inhibiting cancer cell proliferation. Accumulating evidence has shown that chemokines are involved in tumor growth and metastasis. Abnormal function of chemokines in cancer promotes cell survival, facilitated proliferation, angiogenesis, and metastasis in multiple types of tumors. Furthermore, it is believed that chronic inflammatory conditions facilitate oral carcinogenesis, and functions of cytokine-dependent and chemokine-dependent immunoregulatory pathways are apparent in oral carcinoma \[[@b3-medscimonit-23-5924]\]. Thus, neuroactive ligand-receptor interaction and calcium and chemokine signaling pathways represent promising candidates for therapeutic intervention in TSCC patients.

Conclusions
===========

The present study provided an extensive bioinformatics analysis of DEGs and revealed a series of targets and pathways, which may affect the carcinogenesis and progression of TSCC, for future investigation. These findings add to significant insights into the diagnosis and treatment of this disease. However, the absence of experimental validation was a limitation to our study conclusions. Therefore, further experimental studies, with larger sample sizes, are required to validate these findings.
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###### 

Gene ontology analysis of differentially expressed genes associated with TSCC.

  Expression         Category                                                                            Term/gene function                 Gene count   \%         P value
  ------------------ ----------------------------------------------------------------------------------- ---------------------------------- ------------ ---------- ----------
  Up-regulated       GOTERM_BP_DIRECT                                                                    GO: 0007165\~signal transduction   95           9.59       8.67E-05
  GOTERM_BP_DIRECT   GO: 0045944\~positive regulation of transcription from RNA polymerase II promoter   82                                 8.27         1.72E-04   
  GOTERM_BP_DIRECT   GO: 0000122\~negative regulation of transcription from RNA polymerase II promoter   60                                 6.05         0.002      
  GOTERM_BP_DIRECT   GO: 0008285\~negative regulation of cell proliferation                              45                                 4.54         1.50E-05   
  GOTERM_BP_DIRECT   GO: 0007155\~cell adhesion                                                          45                                 4.54         2.35E-04   
  GOTERM_CC_DIRECT   GO: 0005886\~plasma membrane                                                        263                                26.54        6.71E-05   
  GOTERM_CC_DIRECT   GO: 0005829\~cytosol                                                                223                                22.50        8.89E-05   
  GOTERM_CC_DIRECT   GO: 0070062\~extracellular exosome                                                  215                                21.70        1.05E-09   
  GOTERM_CC_DIRECT   GO: 0005576\~extracellular region                                                   141                                14.23        5.09E-10   
  GOTERM_CC_DIRECT   GO: 0005615\~extracellular space                                                    134                                13.52        5.39E-13   
  GOTERM_MF_DIRECT   GO: 0005515\~protein binding                                                        372                                37.53        0.004      
  GOTERM_MF_DIRECT   GO: 0005524\~ATP binding                                                            106                                10.70        0.003      
  GOTERM_MF_DIRECT   GO: 0005509\~calcium ion binding                                                    77                                 7.77         1.41E-08   
  GOTERM_MF_DIRECT   GO: 0042803\~protein homodimerization activity                                      66                                 6.66         5.29E-05   
  GOTERM_MF_DIRECT   GO: 0003700\~transcription factor activity, sequence-specific DNA binding           64                                 6.46         0.003      
  Down-regulated     GOTERM_BP_DIRECT                                                                    GO: 0007165\~signal transduction   83           12.56      6.42E-08
  GOTERM_BP_DIRECT   GO: 0007155\~cell adhesion                                                          57                                 8.62         1.90E-14   
  GOTERM_BP_DIRECT   GO: 0006915\~apoptotic process                                                      47                                 7.11         1.69E-06   
  GOTERM_BP_DIRECT   GO: 0008284\~positive regulation of cell proliferation                              44                                 6.66         2.66E-07   
  GOTERM_BP_DIRECT   GO: 0008285\~negative regulation of cell proliferation                              42                                 6.35         2.26E-08   
  GOTERM_CC_DIRECT   GO: 0005737\~cytoplasm                                                              273                                41.30        3.74E-13   
  GOTERM_CC_DIRECT   GO: 0005634\~nucleus                                                                242                                36.61        3.76E-05   
  GOTERM_CC_DIRECT   GO: 0005829\~cytosol                                                                235                                35.55        1.36E-26   
  GOTERM_CC_DIRECT   GO: 0070062\~extracellular exosome                                                  227                                34.34        9.35E-36   
  GOTERM_CC_DIRECT   GO: 0005886\~plasma membrane                                                        202                                30.56        2.95E-07   
  GOTERM_MF_DIRECT   GO: 0005515\~protein binding                                                        350                                52.95        1.77E-20   
  GOTERM_MF_DIRECT   GO: 0005524\~ATP binding                                                            89                                 13.46        3.73E-05   
  GOTERM_MF_DIRECT   GO: 0044822\~poly(A) RNA binding                                                    65                                 9.83         0.001      
  GOTERM_MF_DIRECT   GO: 0005509\~calcium ion binding                                                    52                                 7.867        2.02E-05   
  GOTERM_MF_DIRECT   GO: 0042802\~identical protein binding                                              46                                 6.96         2.95E-05   

BP -- biological process; CC -- cellular component; MF -- molecular function; Count -- numbers of DEGs; GO -- gene ontology.

###### 

KEGG pathway analysis of differentially expressed genes associated with TSCC.

  Expression       Pathway ID                   Name                 Gene count   \%         P value
  ---------------- ---------------------------- -------------------- ------------ ---------- ----------
  Up-regulated     hsa01100                     Metabolic pathways   110          11.10      0.029
  hsa05200         Pathways in cancer           47                   4.74         0.001      
  hsa04151         PI3K-Akt signaling pathway   39                   3.94         0.011      
  hsa04020         Calcium signaling pathway    37                   3.73         3.28E-08   
  hsa04010         MAPK signaling pathway       36                   3.63         3.35E-04   
  Down-regulated   hsa05200                     Pathways in cancer   47           7.11       4.92E-07
  hsa04151         PI3K-Akt signaling pathway   42                   6.35         1.47E-06   
  hsa04510         Focal adhesion               38                   5.75         6.87E-11   
  hsa04512         ECM-receptor interaction     29                   4.39         4.14E-15   
  hsa05205         Proteoglycans in cancer      29                   4.39         3.33E-06   

hsa -- Homo sapiens; KEGG -- Kyoto Encyclopedia of Genes and Genomes.

###### 

The top 10 differentially expressed genes with higher scores, respectively, identified by the three centrality methods.

  Subgraph   Degree    Closeness                   
  ---------- --------- ----------- ------ -------- ---------
  APP        7.93E10   RAC1        78.0   RAC1     0.01866
  KNG1       7.47E10   APP         74.0   EGFR     0.01864
  AGT        7.20E10   EGFR        59.0   HRAS     0.01863
  RGS19      4.86E10   KNG1        58.0   BCL2     0.01861
  GNAI1      3.64E10   CDK1        56.0   CDC42    0.01860
  GCG        3.51E10   AGT         55.0   HIF1A    0.01860
  ADCY8      3.27E10   HRAS        55.0   PRKCA    0.01860
  ADCY1      3.03E10   CDC42       55.0   CDKN1A   0.01859
  CXCL12     2.97E10   ADCY8       54.0   MMP9     0.01859
  GNA15      2.74E10   GCG         50.0   MAX      0.01858

###### 

GO and pathway analysis of genes in selected module.

  Category           Pathway ID                    Term/gene and function                    Count      P-value
  ------------------ ----------------------------- ----------------------------------------- ---------- ----------
  KEGG_PATHWAY       hsa4080                       Neuroactive ligand-receptor interaction   16         2.83E-17
  hsa4020            Calcium signaling pathway     12                                        1.50E-13   
  hsa4062            Chemokine signaling pathway   12                                        1.50E-13   
  GOTERM_BP_DIRECT   GO.0007165                    Signal transduction                       31         1.74E-10
  GO.0044700         Single organism signaling     29                                        3.40E-08   
  GO.0007154         Cell communication            29                                        5.69E-08   
  GOTERM_CC_DIRECT   GO.0005886                    Plasma membrane                           28         1.20E-07
  GO.0071944         Cell periphery                28                                        1.38E-07   
  GO.0044459         Plasma membrane part          21                                        1.20E-07   
  GOTERM_MF_DIRECT   GO.0005515                    Protein binding                           20         0.0176
  GO.0005102         Receptor binding              19                                        7.39E-11   
  GO.0004871         Signal transducer activity    16                                        5.68E-06   
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